Proteina Co., Ltd. (KOSDAQ:468530)

Market Cap	165.00B
Revenue	n/a
Net Income	n/a
Shares Out	10.78M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	170,473
Average Volume	2,371,710
Open	15,500
Previous Close	15,470
Day's Range	15,110 - 16,210
52-Week Range	13,560 - 25,350
Beta	n/a
RSI	38.50
Earnings Date	n/a

About Proteina

Proteina Co.,Ltd. develops protein-protein interaction profiling technology. The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance. It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information. Proteina Co., Ltd. was founded in 201...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 468530